Bills Search Results

Search all bills

Keyword(s)

Help icon Using the Bill Introduced date fields will allow you to search bills by the date they were introduced into Parliament.
Clicking the 'Bill Introduced (From)' and 'Bill Introduced (To)' fields displays a calendar.
Alternatively select date by typing into these fields in the format 'dd/mm/yyyy'.

Help icon Using the Bill Progress date fields will allow you to search bills by the dates they progressed through Parliament.
Clicking the 'Bill Progress (From)' and 'Bill Progress (To)' fields displays a calendar.
Alternatively select date by typing into these fields in the format 'dd/mm/yyyy'.

Status
Current Bills
Previous Bills
Type

TOTAL RESULTS: 394

Sort

  • National Health Amendment (Pharmaceutical Benefits Transparency and Cost Recovery) Bill 2021

    Track (What's this?)

    Date
    17 Mar 2021 
    Chamber
    Senate 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: establish the statutory authority for the publication of information in relation to the Pharmaceutical Benefits Advisory Committee, including meeting agendas, meeting outcomes, public summary documents and information published on the Medicine Status Website; and provide for cost recovery arrangements, including specifying fees for services and costs incurred to be set out in a disallowable legislative instrument, replacing the existing regulations; and make consequential amendments. 

    Bill | Explanatory Memorandum

  • Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021

    Track (What's this?)

    Date
    03 Feb 2021 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    Narcotic Drugs Act 1967
    to: consolidate the medicinal cannabis licensing structure into a single licence framework; enable assessments relating to supply chains to be undertaken at the permit stage rather than the earlier licensing stage; allow licences to be granted for a period of up to five years; include a new simplified outline; and make minor and technical amendments. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Safety Net Thresholds) Bill 2019

    Track (What's this?)

    Date
    11 Sep 2019 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to reduce the Pharmaceutical Benefits Scheme Safety Net threshold amounts that apply to general and concessional patients. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2019

    Track (What's this?)

    Date
    04 Jul 2019 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: introduce a fee for applications by pharmacists for approval to supply Pharmaceutical Benefits Scheme medicines at particular premises; and enable pharmaceutical benefits to continue temporarily to be supplied following bankruptcy or where there is an external administrator in relation to the pharmacy. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2019

    Track (What's this?)

    Date
    14 Feb 2019 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: introduce a fee for applications by pharmacists for approval to supply Pharmaceutical Benefits Scheme medicines at particular premises; and enable pharmaceutical benefits to continue temporarily to be supplied following bankruptcy or where there is an external administrator in relation to the pharmacy. 

    Bill | Explanatory Memorandum

  • A New Tax System (Medicare Levy Surcharge—Fringe Benefits) Amendment (Excess Levels for Private Health Insurance Policies) Bill 2018

    Track (What's this?)

    Date
    28 Mar 2018 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Part of a package of three bills to increase maximum excess levels for private hospital cover, the bill amends the
    A New Tax System (Medicare Levy Surcharge—Fringe Benefits) Act 1999
    to: give effect to new maximum voluntary excess levels that are permitted for a complying health insurance policy to exempt the holder from the Medicare Levy Surcharge; and remove the grandfathering provisions that provided Medicare levy surcharge exemptions for certain policies that pre-date the commencement of the
    Private Health Insurance Act 2007
    . 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits—Budget and Other Measures) Bill 2017

    Track (What's this?)

    Date
    18 Oct 2017 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: increase the current statutory price reduction that applies when the first new brand of an existing pharmaceutical item is listed on the Pharmaceutical Benefits Scheme (PBS); extend and introduce statutory price reductions applying on certain anniversaries of an F1 formulary drug being listed on the PBS; introduce ministerial discretion in relation to the application of statutory price reductions in certain circumstances; make minor amendments to price disclosure arrangements; provide new circumstances whereby a new presentation of a brand of pharmaceutical item may be listed without being subject to a new brand statutory price reduction; continue the operation of the Australian Community Pharmacy Authority and the pharmacy location rules beyond 30 June 2020; and make technical amendments. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2016

    Track (What's this?)

    Date
    24 Nov 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: enable the minister, the secretary or the Chief Executive Medicare to arrange for the use of computer programs to make decisions and determinations, exercise powers or comply with obligations and do anything else related to those actions; enable approved pharmacists whose premises have been affected by disaster or exceptional circumstances to supply pharmaceutical benefits at alternative premises in the same locality for a limited period and be paid for claims at the full rate; and ensure that entitlements for concessional beneficiaries and their dependants will apply for pharmaceutical benefits until midnight on the day of a person’s death. 

    Bill | Explanatory Memorandum

  • Narcotic Drugs (Licence Charges) Bill 2016

    Track (What's this?)

    Date
    14 Sep 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the Narcotic Drugs Legislation Amendment Bill 2016, the bill imposes charges on licences granted under the
    Narcotic Drugs Act 1967
    to enable the Commonwealth to recover the costs of the administration, monitoring and assessment of compliance under the Act after the licence and permits associated with the licence are granted. 

    Bill | Explanatory Memorandum

  • Narcotic Drugs Legislation Amendment Bill 2016

    Track (What's this?)

    Date
    14 Sep 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the Narcotic Drugs (Licence Charges) Bill 2016, the bill amends the
    Narcotic Drugs Act 1967
    to: protect sensitive law enforcement information that may be disclosed by law enforcement agencies for the purposes of regulatory action relating to medicinal cannabis licences, cannabis research licences and manufacture licences; introduce an offence for the unauthorised disclosure of sensitive law enforcement information in certain circumstances; clarify that cannabis research licence holders can supply seeds to licensed cultivators; enable the minister to make standards and guidelines; enable the making of regulations to specify periods within which the secretary must notify licence holders of certain matters; provide for the timing of payments of fees and charges; and enable the pro-rating refund, waiving, reduction or remission of fees; and the
    Therapeutic Goods Act 1989
    to enable regulations to be made prescribing the circumstances in which the use of medicinal cannabis products can be authorised. 

    Bill | Explanatory Memorandum

Senator/Member search

Browse all Senators and Members